marketcaparena
Search

    CNTB

    Connect Biopharma Holdings Ltd

    Company overview

    Market capitalization
    $68.01M
    Employees
    64
    Latest publication
    2026-09-29
    About Connect Biopharma Holdings Ltd

    Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue2,768,000USD169,000USD16,000USD16,000USD48,000USD0USD698,000USD1,219,000USD
    Research Development16,273,000USD15,030,000USD11,282,000USD11,110,000USD8,773,000USD6,633,000USD6,236,000USD9,009,000USD
    Selling General Administrative4,099,000USD4,746,000USD4,244,000USD6,583,000USD4,699,000USD4,814,000USD4,081,000USD6,056,000USD
    General And Administrative Expenses4,099,000USD———————
    Total Operating Expenses20,372,000USD19,776,000USD15,526,000USD17,693,000USD13,472,000USD11,447,000USD10,317,000USD15,065,000USD
    Operating Income-17,604,000USD-19,607,000USD-15,526,000USD-17,677,000USD-13,424,000USD-11,447,000USD-9,619,000USD-13,846,000USD
    Total Other Income Expense Net380,000USD-3,000USD444,000USD-7,000USD580,000USD509,000USD819,000USD-108,000USD
    Income Before Tax-17,224,000USD-19,350,000USD-15,082,000USD-17,139,000USD-12,844,000USD-10,218,000USD-8,800,000USD-12,819,000USD
    Income Tax Expense60,000USD—27,000USD—55,000USD—106,000USD—
    Net Income-17,284,000USD-19,398,000USD-15,109,000USD-17,200,000USD-12,899,000USD-10,272,000USD-8,906,000USD-12,876,000USD
    Interest Income—260,000USD384,000USD545,000USD619,000USD720,000USD849,000USD1,135,000USD
    Net Interest Income—260,000USD384,000USD545,000USD619,000USD720,000USD849,000USD1,135,000USD
    Tax Provision—48,000USD27,000USD61,000USD55,000USD54,000USD106,000USD57,000USD
    Net Income From Continuing Ops—-19,398,000USD-15,109,000USD-17,200,000USD-12,899,000USD-10,272,000USD-8,906,000USD-12,876,000USD
    Reconciled Depreciation—164,000USD181,000USD179,000USD171,000USD173,000USD158,000USD176,000USD
    Gross Profit——16,000USD—48,000USD—698,000USD—
    Ebit——-15,526,000USD—-13,424,000USD—-9,619,000USD—
    Ebitda——-15,345,000USD—-13,253,000USD—-9,461,000USD—
    Depreciation And Amortization——181,000USD—171,000USD—158,000USD—
    Cost Of Revenue——————183,528USD—
    Interest Expense——————20,000USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · CNYFY 20212021-12-31 · CNYFY 20202020-12-31 · CNYFY 20192019-12-31 · CNYFY 20182018-12-31 · CNY
    Total Revenue64,000USD26,033,000USD0USD0CNY0CNY0CNY0CNY—
    Gross Profit64,000USD26,033,000USD-988,000USD-1,030,634CNY————
    Research Development37,798,000USD29,256,000USD53,002,000USD96,630,000CNY80,496,000CNY23,121,273CNY15,438,239CNY—
    Selling General Administrative20,340,000USD19,229,000USD16,054,000USD20,806,000CNY19,014,000CNY7,310,227CNY1,409,134CNY—
    Total Operating Expenses58,138,000USD48,485,000USD69,056,000USD119,316,000CNY98,107,000CNY29,360,854CNY16,435,934CNY—
    Operating Income-58,074,000USD-22,452,000USD-69,056,000USD-119,316,000CNY-98,107,000CNY-30,295,313CNY-15,993,449CNY—
    Interest Income2,268,000USD4,453,000USD2,714,000USD10,715,000CNY622,000CNY717,000CNY1,066,000CNY—
    Net Interest Income2,268,000USD4,453,000USD2,691,000USD10,571,000CNY578,000CNY-2,176,000CNY1,013,000CNY—
    Income Before Tax-55,283,000USD-15,405,000USD-61,986,000USD-117,793,000CNY-202,000,000CNY-119,369,477CNY-24,463,633CNY—
    Income Tax Expense197,000USD223,000USD120,000USD298,000CNY266,000CNY934,459CNY-442,485CNY—
    Tax Provision197,000USD223,000USD120,000USD2,037,000CNY1,697,000CNY0CNY0CNY—
    Net Income-55,480,000USD-15,628,000USD-62,106,000USD-118,091,000CNY-202,266,000CNY-119,369,477CNY-24,463,633CNY—
    Net Income From Continuing Ops-55,480,000USD-15,628,000USD-59,503,000USD-797,055,000CNY-1,306,824,000CNY-779,225,000CNY-168,625,000CNY—
    Ebit-58,074,000USD-22,452,000USD-69,056,000USD-117,772,000CNY-201,993,000CNY-118,428,584CNY-24,898,428CNY-66,017,000CNY
    Ebitda-57,370,000USD-21,792,000USD-68,336,000USD-116,741,000CNY-201,359,000CNY-118,207,531CNY-24,783,818CNY—
    Depreciation And Amortization704,000USD660,000USD720,000USD1,031,000CNY634,000CNY221,053CNY114,610CNY—
    Reconciled Depreciation704,000USD660,000USD988,000USD6,940,000CNY4,082,000CNY1,443,000CNY790,000CNY—
    Total Other Income Expense Net2,791,000USD7,047,000USD7,070,000USD1,523,000CNY-103,893,000CNY-89,675,281CNY-8,174,661CNY—
    Cost Of Revenue—660,000USD988,000USD1,030,634CNY————
    Interest Expense——23,000USD21,032CNY6,909CNY6,434CNY7,689CNY0CNY
    Unclassified Operating Expenses———1,880,000CNY-1,403,000CNY-1,070,646CNY——
    Net Income Applicable To Common Shares————-1,306,824,000CNY-779,225,000CNY-168,625,000CNY-76,965,000CNY
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ2 20242024-06-30 · USD
    Total Assets43,472,000USD60,066,000USD56,075,000USD67,361,000USD82,725,000USD92,685,000USD101,284,000USD120,570,000USD
    Cash And Equivalents27,015,000USD———————
    Cash And Short Term Investments31,486,000USD—44,342,000USD—71,768,000USD—93,708,000USD110,174,000USD
    Short Term Investments4,471,000USD0USD5,997,000USD16,936,000USD31,136,000USD36,286,000USD15,476,000USD67,000USD
    Total Current Assets38,623,000USD55,020,000USD50,929,000USD62,597,000USD77,756,000USD87,755,000USD96,961,000USD115,898,000USD
    Other Current Assets4,201,000USD470,000USD6,426,000USD517,000USD5,795,000USD65,000USD2,202,000USD1,876,000USD
    Other Non Current Assets646,000USD———————
    Total Liabilities16,611,000USD———————
    Total Current Liabilities16,301,000USD17,045,000USD13,613,000USD11,427,000USD10,741,000USD8,565,000USD8,462,000USD9,624,000USD
    Other Current Liabilities13,892,000USD———————
    Other Non Current Liabilities107,000USD———————
    Total Stockholder Equity26,861,000USD42,623,000USD41,980,000USD55,371,000USD71,342,000USD82,899,000USD92,166,000USD110,479,000USD
    Total Equity Including Noncontrolling Interest26,861,000USD———————
    Deferred Revenue0USD———————
    Net Receivables2,936,000USD0USD161,000USD17,000USD193,000USD8,000USD1,051,000USD3,848,000USD
    Property Plant Equipment Net4,161,000USD4,357,000USD4,455,000USD4,672,000USD4,876,000USD4,835,000USD4,237,000USD4,519,000USD
    Accounts Payable2,016,000USD4,306,000USD1,964,000USD1,994,000USD2,294,000USD817,000USD342,000USD5,701,000USD
    Short Term Debt393,000USD—322,000USD—350,000USD—154,000USD252,000USD
    Common Stock11,000USD—10,000USD—10,000USD—10,000USD10,000USD
    Retained Earnings-437,517,000USD-420,233,000USD-400,835,000USD-385,726,000USD-368,526,000USD-355,627,000USD-345,355,000USD-531,698,000USD
    Accumulated Other Comprehensive Income-962,000USD—-1,191,000USD—-1,375,000USD—-1,666,000USD-8,045,000USD
    Total Liab—17,443,000USD14,095,000USD11,990,000USD11,383,000USD9,786,000USD9,118,000USD10,091,000USD
    Capital Stock—11,000USD10,000USD10,000USD10,000USD10,000USD10,000USD10,000USD
    Cash—46,034,000USD38,345,000USD37,845,000USD40,632,000USD47,709,000USD78,232,000USD110,174,000USD
    Property Plant Equipment Gross—4,357,000USD7,746,000USD4,672,000USD4,876,000USD4,835,000USD6,865,000USD8,059,000USD
    Common Stock Shares Outstanding—56,521,282shares55,660,000shares55,786,000shares55,498,000shares55,352,000shares55,190,172shares55,554,249shares
    Non Current Assets Total—5,046,000USD5,146,000USD4,764,000USD4,969,000USD4,930,000USD4,323,000USD4,672,000USD
    Non Current Liabilities Total—398,000USD482,000USD563,000USD642,000USD1,221,000USD656,000USD467,000USD
    Non Current Liabilities Other—111,000USD114,000USD118,000USD122,000USD627,000USD632,000USD—
    Non Currrent Assets Other—646,000USD646,000USD45,000USD45,000USD45,000USD33,000USD96,000USD
    Net Working Capital—37,975,000USD37,316,000USD51,170,000USD67,015,000USD79,190,000USD88,499,000USD106,274,000USD
    Unclassified Current Assets—8,516,000USD—7,282,000USD—3,687,000USD——
    Unclassified Current Liabilities—12,739,000USD—9,433,000USD—7,748,000USD—-3,158,000USD
    Unclassified Equity—462,845,000USD443,986,000USD441,087,000USD441,223,000USD438,516,000USD439,167,000USD650,202,000USD
    Intangible Assets——45,000USD—48,000USD—53,000USD57,000USD
    Other Current Liab——11,160,000USD—7,933,000USD—7,802,000USD3,671,000USD
    Current Deferred Revenue——167,000USD—164,000USD—164,000USD3,158,000USD
    Net Debt——-37,655,000USD—-39,762,000USD—-78,054,000USD-109,849,000USD
    Short Long Term Debt Total——690,000USD—870,000USD—178,000USD325,000USD
    Other Assets———————1USD
    Inventory———————-287,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · CNYFY 20212021-12-31 · CNYFY 20202020-12-31 · CNYFY 20192019-12-31 · CNYFY 20182018-12-31 · CNY
    Total Assets56,075,000USD101,284,000USD127,375,000USD174,013,000CNY291,053,000CNY25,437,540CNY7,725,531CNY69,286,603CNY
    Intangible Assets45,000USD53,000USD62,000USD3,165,000CNY3,537,000CNY8,019CNY——
    Other Current Assets6,426,000USD2,202,000USD3,899,000USD3,130,000CNY7,412,000CNY748,540CNY456,102CNY2,414,521CNY
    Total Liab14,095,000USD9,118,000USD25,878,000USD16,521,000CNY18,795,000CNY49,470,008CNY13,910,448CNY88,699,151CNY
    Total Stockholder Equity41,980,000USD92,166,000USD101,497,000USD157,492,000CNY272,258,000CNY-24,032,468CNY-6,184,916CNY-19,412,547CNY
    Other Current Liab11,160,000USD7,802,000USD9,479,000USD3,501,000CNY5,151,000CNY299,072CNY87,024CNY409,895CNY
    Common Stock10,000USD10,000USD10,000USD10,000CNY10,000CNY563CNY435CNY3,208CNY
    Capital Stock10,000USD10,000USD10,000USD66,000CNY66,000CNY24,000CNY21,000CNY—
    Retained Earnings-400,835,000USD-345,355,000USD-329,727,000USD-479,844,000CNY-361,753,000CNY-25,120,341CNY-6,056,962CNY-18,862,368CNY
    Cash38,345,000USD78,232,000USD105,663,000USD79,010,000CNY267,716,000CNY23,683,826CNY6,406,467CNY61,341,073CNY
    Cash And Short Term Investments44,342,000USD93,708,000USD118,303,000USD152,417,000CNY267,716,000CNY23,990,239CNY7,041,615CNY65,922,442CNY
    Total Current Assets50,929,000USD96,961,000USD122,553,000USD155,779,000CNY275,128,000CNY24,779,367CNY7,522,828CNY68,081,309CNY
    Total Current Liabilities13,613,000USD8,462,000USD25,293,000USD15,624,000CNY17,985,000CNY890,937CNY568,070CNY966,556CNY
    Current Deferred Revenue167,000USD164,000USD13,320,000USD—————
    Net Debt-37,655,000USD-78,054,000USD-105,198,000USD-78,579,000CNY-267,591,000CNY-23,662,418CNY-6,388,179CNY26,391,521CNY
    Short Term Debt322,000USD154,000USD285,000USD186,000CNY99,000CNY14,162CNY8,542CNY56,989CNY
    Short Long Term Debt Total690,000USD178,000USD465,000USD431,000CNY125,000CNY21,407CNY18,287CNY87,732,595CNY
    Short Term Investments5,997,000USD15,476,000USD12,640,000USD73,407,000CNY677CNY306,412CNY635,147CNY371,012CNY
    Net Receivables161,000USD1,051,000USD351,000USD232,000CNY7,412,000CNY40,587CNY25,109CNY370,000CNY
    Accounts Payable1,964,000USD342,000USD2,209,000USD11,937,000CNY12,735,000CNY577,701CNY472,504CNY499,672CNY
    Property Plant Equipment Net4,455,000USD4,237,000USD4,736,000USD5,377,000CNY9,438,000CNY184,485CNY70,954CNY479,612CNY
    Property Plant Equipment Gross7,746,000USD6,865,000USD7,795,000USD51,524,000CNY82,158,000CNY20,153,000CNY5,152,000CNY—
    Accumulated Other Comprehensive Income-1,191,000USD-1,666,000USD-1,008,000USD-7,628,000CNY-4,028,000CNY-39,696CNY-1,010,302CNY-6,368,766CNY
    Common Stock Shares Outstanding55,660,000shares55,213,000shares55,067,000shares55,044,000shares52,272,960shares53,941,675shares55,816,675shares—
    Non Current Assets Total5,146,000USD4,323,000USD4,822,000USD18,234,000CNY15,925,000CNY658,173CNY202,703CNY1,205,293CNY
    Non Current Liabilities Total482,000USD656,000USD585,000USD897,000CNY810,000CNY48,579,071CNY13,342,377CNY87,732,595CNY
    Non Current Liabilities Other114,000USD632,000USD405,000USD——2,071,508,000CNY643,008,000CNY—
    Non Currrent Assets Other646,000USD33,000USD24,000USD252,000CNY2,950,000CNY465,668CNY131,748CNY725,681CNY
    Net Working Capital37,316,000USD88,499,000USD96,707,000USD976,120,000CNY1,639,470,000CNY1,018,802,000CNY335,415,000CNY—
    Unclassified Equity443,986,000USD439,167,000USD432,212,000USD644,888,000CNY637,963,000CNY1,103,006CNY—5,815,379CNY
    Long Term Investments——0USD65,744,000CNY0CNY———
    Inventory——-13,950,712USD-6,421,974CNY-6,743CNY4,883,874CNY3,184,095CNY—
    Other Assets———0CNY18,806,000CNY19,860,000CNY6,354,000CNY4,751,000CNY
    Unclassified Non Current Assets———-56,304,000CNY-18,806,000CNY-19,859,999CNY-6,353,999CNY-4,751,000CNY
    Other Liab————5,000,000CNY———
    Good Will————-3,452,531CNY———
    Net Tangible Assets————1,735,271,000CNY-1,025,287,000CNY-298,287,000CNY-127,093,000CNY
    Unclassified Current Assets————-7,412,677CNY-4,883,872CNY-3,184,092CNY3,584,703CNY
    Unclassified Non Current Liabilities————-4,190,000CNY-2,022,928,929CNY-629,665,623CNY87,732,595CNY
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-19,398,000USD-15,109,000USD-122,378,000USD-12,899,000USD-10,272,000USD-23,217,291USD-12,876,000USD6,154,000USD
    Depreciation164,000USD181,000USD179,000USD171,000USD173,000USD184,000USD176,000USD326,000USD
    Stock Based Compensation1,199,000USD917,000USD916,000USD951,000USD942,000USD4,889,000USD2,022,000USD3,305,000USD
    Change To Account Receivables13,000USD4,000USD-17,000USD8,000USD781,000USD2,426,023USD-5,021,000USD-3,930,000USD
    Change In Working Capital2,037,000USD2,825,000USD-1,132,000USD-526,000USD-587,000USD2,440,733USD-2,336,000USD-17,972,000USD
    Total Cash From Operating Activities-16,005,000USD-11,250,000USD-17,406,000USD-12,591,000USD-9,959,000USD-15,577,432USD-13,007,000USD-8,286,000USD
    Capital Expenditures0USD-16,000USD-34,000USD-303,000USD-81,000USD-312,077USD-147,000USD-436,000USD
    Free Cash Flow-16,005,000USD-11,266,000USD-17,440,000USD-12,894,000USD-10,040,000USD-15,889,510USD-13,154,000USD-8,410,000USD
    Investments6,000,000USD11,000,000USD14,380,000USD5,129,000USD-20,562,000USD-15,764,000USD0USD3,027,000USD
    Total Cash From Financing Activities17,622,000USD715,000USD215,000USD161,000USD2,000USD272,417USD0USD121,000USD
    Issuance Of Capital Stock17,485,000USD———0USD———
    Change In Cash7,689,000USD500,000USD-2,787,000USD-7,077,000USD-30,523,000USD-31,942,000USD-12,647,000USD28,994,906USD
    Begin Period Cash Flow38,345,000USD37,845,000USD40,632,000USD47,709,000USD78,232,000USD110,174,000USD109,839,000USD81,179,094USD
    End Period Cash Flow46,034,000USD38,345,000USD37,845,000USD40,632,000USD47,709,000USD78,232,000USD97,192,000USD110,174,000USD
    Other Non Cash Items—-64,000USD—-288,000USD—126,126USD—-99,000USD
    Total Cashflows From Investing Activities—10,984,000USD—5,129,000USD—-15,719,147USD—12,460,000USD
    Other Cashflows From Investing Activities—7,489,000USD———2,258,924USD—13,149,000USD
    Other Cashflows From Financing Activities—-500,000USD—161,000USD—-142,000USD—-46,000USD
    Unclassified Investing Cash Flow—-7,489,000USD———-1,901,994USD—-3,280,000USD
    Unclassified Financing Cash Flow—1,215,000USD——————
    Unclassified Operating Cash Flow——105,009,000USD—————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · CNYFY 20212021-12-31 · CNYFY 20202020-12-31 · CNYFY 20192019-12-31 · CNYFY 20182018-12-31 · CNY
    Net Income-55,480,000USD-15,628,000USD-59,383,000USD-116,117,679CNY-1,305,127,000CNY-119,369,477CNY-24,463,633CNY-76,965,000CNY
    Depreciation704,000USD660,000USD988,000USD1,013,633CNY4,082,000CNY221,053CNY114,610CNY631,000CNY
    Stock Based Compensation3,726,000USD6,728,000USD3,259,000USD1,008,813CNY57,863,000CNY590,644CNY562,173CNY—
    Other Non Cash Items-736,000USD118,000USD-2,279,000USD-1,350,732CNY44,000CNY443,178CNY7,689CNY—
    Change To Account Receivables776,000USD-789,000USD1,044,000USD3,372CNY-16,116,000CNY-1,432CNY-439CNY-7,011,000CNY
    Change In Working Capital580,000USD-15,490,000USD9,485,000USD7,160,135CNY20,820,000CNY-436,285CNY2,382,166CNY-4,489,000CNY
    Total Cash From Operating Activities-51,206,000USD-23,612,000USD-47,930,000USD-99,269,604CNY-544,926,000CNY-25,607,393CNY-13,094,082CNY-69,032,000CNY
    Capital Expenditures-434,000USD-750,000USD-294,000USD-4,282,381CNY-47,529,000CNY-2,344,420CNY-155,523CNY-1,190,000CNY
    Free Cash Flow-51,640,000USD-24,362,000USD-48,224,000USD-103,551,985CNY-592,455,000CNY-27,951,813CNY-13,249,605CNY—
    Investments10,250,000USD-3,451,000USD75,155,000USD-571,310,000CNY13,504,000CNY18,236,000CNY-2,269,000CNY59,265,000CNY
    Total Cashflows From Investing Activities9,818,000USD-3,451,000USD75,155,000USD-83,443,634CNY-34,025,000CNY449,153CNY-484,703CNY58,075,000CNY
    Total Cash From Financing Activities1,093,000USD227,000USD-246,000USD-91,285CNY1,316,099,000CNY140,744,997CNY-57,451CNY368,955,000CNY
    Change In Cash-39,887,000USD-27,431,000USD26,997,000USD-168,930,017CNY696,804,000CNY107,402,121CNY-13,437,770CNY360,664,000CNY
    Begin Period Cash Flow78,232,000USD105,663,000USD79,010,000USD249,301,203CNY1,010,076,000CNY47,331,420CNY58,262,545CNY—
    End Period Cash Flow38,345,000USD78,232,000USD106,007,000USD80,371,186CNY1,706,880,000CNY154,733,542CNY44,824,774CNY401,597,000CNY
    Other Cashflows From Investing Activities775,000USD123,000USD-84,000USD-79,161CNY-22,284,000CNY-53,463CNY-329CNY-22,284,000CNY
    Other Cashflows From Financing Activities1,093,000USD227,000USD75,155,000USD119,000CNY-110,954,000CNY140,828,302CNY7,003CNY-9,859,000CNY
    Net Borrowings——-290,000USD-222,000CNY-805,000CNY-538,000CNY-445,000CNY-334,000CNY
    Sale Purchase Of Stock——0USD0CNY-3,674,000CNY0CNY0CNY—
    Issuance Of Capital Stock——44,000USD132,000CNY1,431,775,000CNY0CNY0CNY—
    Unclassified Financing Cash Flow——-75,111,000USD—1,431,775,000CNY——379,148,000CNY
    Change To Inventory———-3,372CNY16,116CNY1,432CNY439CNY—
    Unclassified Operating Cash Flow———9,016,226CNY677,392,000CNY92,943,494CNY8,302,913CNY11,791,000CNY
    Unclassified Investing Cash Flow———492,227,908CNY22,284,000CNY-15,388,964CNY1,940,149CNY22,284,000CNY
    Change To Liabilities————56,601,000CNY1,850,000CNY19,351,000CNY2,522,000CNY
    Dividends Paid————-243,000CNY———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    FY 2024Yearly · 2024-12-31ProductClinical Trial Reports1,600,000USD0001835268-26-000013
    FY 2024Yearly · 2024-12-31ProductLicense24,400,000USD0001835268-26-000013

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.